BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

247 related articles for article (PubMed ID: 12708702)

  • 1. Pulsed corticosteroid therapy in patients with chronic recurrent ENL: a pilot study.
    Girdhar A; Chakma JK; Girdhar BK
    Indian J Lepr; 2002; 74(3):233-6. PubMed ID: 12708702
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Pentoxifylline in the treatment of erythema nodosum leprosum: results of an open study].
    de Carsalade GY; Achirafi A; Flageul B
    Acta Leprol; 2003; 12(3):117-22. PubMed ID: 15040702
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Pentoxifylline in the treatment of erythema nodosum leprosum.
    De Carsalade GY; Achirafi A; Flageul B
    J Dermatol; 2003 Jan; 30(1):64-8. PubMed ID: 12598712
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Role of azathioprine in preventing recurrences in a patient of recurrent erythema nodosum leprosum.
    Verma KK; Srivastava P; Minz A; Verma K
    Lepr Rev; 2006 Sep; 77(3):225-9. PubMed ID: 17172003
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effect of rhuIFN-gamma treatment in multibacillary leprosy patients.
    Sampaio EP; Malta AM; Sarno EN; Kaplan G
    Int J Lepr Other Mycobact Dis; 1996 Sep; 64(3):268-73. PubMed ID: 8862260
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The role of thalidomide in the management of erythema nodosum leprosum.
    Walker SL; Waters MF; Lockwood DN
    Lepr Rev; 2007 Sep; 78(3):197-215. PubMed ID: 18035771
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Erythema nodosum leprosum in Nepal: a retrospective study of clinical features and response to treatment with prednisolone or thalidomide.
    Feuth M; Brandsma JW; Faber WR; Bhattarai B; Feuth T; Anderson AM
    Lepr Rev; 2008 Sep; 79(3):254-69. PubMed ID: 19009975
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Risk factors for erythema nodosum leprosum.
    Manandhar R; LeMaster JW; Roche PW
    Int J Lepr Other Mycobact Dis; 1999 Sep; 67(3):270-8. PubMed ID: 10575406
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Thalidomide levels in patients with erythema nodosum leprosum.
    Vieira JL; Valente Mdo S
    Ther Drug Monit; 2009 Oct; 31(5):602-3. PubMed ID: 19704404
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Deep vein thrombosis: a rare complication of thalidomide therapy in recurrent erythema nodosum leprosum.
    Sharma NL; Sharma V; Shanker V; Mahajan VK; Sarin S
    Int J Lepr Other Mycobact Dis; 2004 Dec; 72(4):483-5. PubMed ID: 15755204
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Does clofazimine prevent erythema nodosum leprosum (ENL) in leprosy? A retrospective study, comparing the experience of multibacillary patients receiving either 12 or 24 months WHO-MDT.
    Balagon M; Saunderson PR; Gelber RH
    Lepr Rev; 2011 Sep; 82(3):213-21. PubMed ID: 22125929
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Necrotic erythema nodosum leprosum with oral mucosal involvement.
    Swain JP; Soud A; Agarwal SK
    Indian J Lepr; 2008; 80(2):175-8. PubMed ID: 19425513
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Oral zinc therapy in recurrent erythema nodosum leprosum: a clinical study.
    Mahajan PM; Jadhav VH; Patki AH; Jogaikar DG; Mehta JM
    Indian J Lepr; 1994; 66(1):51-7. PubMed ID: 7983392
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Erythema Nodosum Leprosum: Update and challenges on the treatment of a neglected condition.
    Costa PDSS; Fraga LR; Kowalski TW; Daxbacher ELR; Schuler-Faccini L; Vianna FSL
    Acta Trop; 2018 Jul; 183():134-141. PubMed ID: 29474830
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Using methotrexate to treat patients with ENL unresponsive to steroids and clofazimine: a report on 9 patients.
    Hossain D
    Lepr Rev; 2013 Mar; 84(1):105-12. PubMed ID: 23741889
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Interventions for erythema nodosum leprosum.
    Van Veen NH; Lockwood DN; van Brakel WH; Ramirez J; Richardus JH
    Cochrane Database Syst Rev; 2009 Jul; (3):CD006949. PubMed ID: 19588412
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Case Report: Rapid Response to Low-Dose Thalidomide in a Case of Severe Steroid Recalcitrant Erythema Nodosum Leprosum.
    Savitha B; Sardana K; Kumari R; Khurana A; Sinha S; Sachdeva S
    Am J Trop Med Hyg; 2021 Oct; 106(1):51-53. PubMed ID: 34662871
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Severe form of type 2 reaction in patients of Hansen's disease after withdrawal of thalidomide: case reports.
    Rattan R; Shanker V; Tegta GR; Verma GK
    Indian J Lepr; 2009; 81(4):199-203. PubMed ID: 20704076
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Thalidomide and steroid in the management of erythema nodosum leprosum.
    P K Mishra SR; Samal R; Behera B
    Indian J Pharmacol; 2022; 54(3):177-182. PubMed ID: 35848688
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Comparison of the efficacy and safety of minocycline and clofazimine in chronic and recurrent erythema nodosum leprosum-A randomized clinical trial.
    Hanumanthu V; Thakur V; Narang T; Dogra S
    Dermatol Ther; 2021 Nov; 34(6):e15125. PubMed ID: 34490707
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.